About Astrion

We aims to develop therapies for incurable neurological diseases, including Brain tumors, Schizophrenia, Dementia, Parkinson's, and Huntington's

We strive to enhance the quality of life and offer hope for longer life to patients enduring neurological disorders

Learn More

Astrion is dedicated to preserving the health and happiness of more people with top experts

Explore Key Personnel

Key Personnel and Organizational Chart Leading Astrion
 
 

Explore R&D

Ion Channel Function Modulation-Based Platform (mCBA) and Gold Nanoparticle-Based Cognitive Enhancement Drug Screening System Technology (PNACS)

Explore Pipeline

Building a pipeline for R&D of various treatments for intractable neurological diseases based on a specialized drug screening platform technology

NEWS & NOTICE

Check out the latest news and announcements from Astrion.

Image
March 11th

<News> Signing a Joint Development Agreement for a New Drug for 'Germ Cell Tumors' with Kolon Pharma...

Learn More
Image
November 20th

<News> Astrion Participated in the 2nd Promising Bioventure and Startup Investment Forum in 2023...

Learn More
Image
November 17th

<News> Astrion Participated in Bio Europe 2023: Engaging in Collaborative Research and Licensing...

Learn More